Procarcinogen activation by rat and human mammary extracts

Area of Science:

• Biochemistry
• Toxicology
• Oncology

Background:

• Sprague-Dawley rat mammary glands are highly susceptible to polycyclic aromatic hydrocarbon-induced tumorigenesis.
• Understanding the metabolic activation of procarcinogens is crucial for assessing mammary gland cancer risk.

Purpose of the Study:

• To quantitatively assess the in vitro mutagenic activation of procarcinogens by rat mammary gland S9 fractions.
• To investigate the role of enzyme induction and inhibition in mammary gland procarcinogen metabolism.
• To compare procarcinogen activation in rat mammary tissue with human mammary tumor cell lines.

Main Methods:

• Utilized the Ames test with a nicotinamide adenine dinucleotide phosphate (NADPH) generating system to evaluate mutagenic activation.
• Administered 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) to rats to induce specific enzyme activities in mammary tissue.
• Employed enzyme inhibitors alpha-naphthoflavone (alpha NF) and metyrapone (MP) to study metabolic pathways.
• Assessed procarcinogen metabolism in human mammary tumor cell lines (734B, SkBr3, MDA-MD-330).

Main Results:

• Rat mammary S9 activated 2-aminoanthracene (2-AA), with activity significantly increased by TCDD pre-treatment.
• TCDD induction enabled the detection of 2,4-diaminoanisole (DAA) and 2,7-diaminofluorene (DAF) activation.
• 2-aminofluorine (2-AF), benzo[a]pyrene (BP), and aflatoxin B1 (AFL) were not detectably activated.
• Mutagenesis from 2-AA, DAA, or DAF activation was significantly inhibited by alpha NF but minimally by metyrapone.
• Human mammary tumor cell lines exhibited inducible procarcinogen metabolizing activities similar to rat mammary S9.

Conclusions:

• The Ames test provides a reliable method for characterizing procarcinogen activation in rat mammary glands.
• Enzyme induction by TCDD enhances the detection of specific procarcinogen activations.
• Differential inhibition by alpha NF and metyrapone suggests distinct metabolic pathways involved in mammary tumorigenesis.
• The findings indicate conserved procarcinogen metabolizing activities between rat and human mammary tissues.